CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

Go back to CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
(NASDAQ: CNSP) Delayed: 5.83 -0.03 (0.51%)
Previous Close $5.86    52 Week High
Open $6.07    52 Week Low
Day High $6.19    P/E N/A 
Day Low $5.70    EPS
Volume 21,429